Nov 06, 2023 / 09:30PM GMT
Operator
Good afternoon, and welcome to the Voyager Therapeutics Third Quarter 2023 Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request. A replay of today's call will be available on the Investors section of the company's website approximately 2 hours after completion of this call. I would now like to turn the call over to Pete Pfreundschuh, Chief Financial Officer. You may begin.
Peter P. Pfreundschuh - Voyager Therapeutics, Inc. - CFO
Thank you, and good afternoon. Joining me on the call today is Dr. Al Sandrock, our CEO. And joining us for Q&A is Dr. Todd Carter, our Chief Scientific Officer. We issued our Q3 2023 financial results press release this afternoon. The press release and 10-Q are available on our website.
In a moment, I will turn the call over to Al. Before I do this, I want to remind everyone that during the call, Voyager representatives may make forward-looking statements as noted in Slide 2 of today's deck. These forward-looking statements include future expectations,
Q3 2023 Voyager Therapeutics Inc Earnings Call Transcript
Mar 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers